Analyst Ratings For Genus plc (LON:GNS)
Today, Liberum Capital reiterated its Hold rating on Genus plc (LON:GNS).
There are 3 Buy Ratings, 2 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on Genus plc (LON:GNS) is Buy with a consensus target price of GBX 2,416 per share, a potential .
Some recent analyst ratings include
- 2/28/2019-Genus plc (LON:GNS) had its Hold rating reiterated by Liberum Capital
- 2/28/2019-Genus plc (LON:GNS) had its Buy rating reiterated by Peel Hunt
- 2/12/2019-Genus plc (LON:GNS) has coverage initiated with a Buy rating and GBX 2,650 price target
- 3/1/2018-Genus plc (LON:GNS) had its Hold rating reiterated by Berenberg Bank with a GBX 1,800 price target
- 11/16/2017-Genus plc (LON:GNS) had its Buy rating reiterated by N+1 Singer
- 9/7/2017-Genus plc (LON:GNS) had its Hold rating reiterated by Numis Securities with a GBX 1,815 price target
About Genus plc (LON:GNS)
Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos, which are delivered through artificial insemination to breed dairy and beef cattle with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in vitro fertilization, reproductive, and other technical services to farmers; and agricultural and agri-food consultancy services. Genus plc was incorporated in 1994 and is headquartered in Basingstoke, the United Kingdom.
Recent Trading Activity for Genus plc (LON:GNS)
Shares of Genus plc closed the previous trading session at 158,00 −42,00 1,91 % with shares trading hands.
